Literature DB >> 27095310

Rapid-Growing Mycobacteria Infections in Medical Tourists: Our Experience and Literature Review.

Mansher Singh1, Caitlin M Dugdale1, Isaac H Solomon1, Anne Huang1, Mary W Montgomery1, Bohdan Pomahac1, Sigal Yawetz1, James H Maguire1, Simon G Talbot1.   

Abstract

BACKGROUND: "Medical tourism" has gained popularity over the past few decades. This is particularly common with patients seeking elective cosmetic surgery in the developing world. However, the risk of severe and unusual infectious complications appears to be higher than for patients undergoing similar procedures in the United States.
OBJECTIVES: The authors describe their experience with atypical mycobacterial infections in cosmetic surgical patients returning to the United States postoperatively.
METHODS: A review of patient medical records presenting with infectious complications after cosmetic surgery between January 2010 and July 2015 was performed. Patients presenting with mycobacterial infections following cosmetic surgery were reviewed in detail. An extensive literature review was performed for rapid-growing mycobacteria (RGM) related to cosmetic procedures.
RESULTS: Between January 2010 and July 2015, three patients presented to our institution with culture-proven Mycobacterium abscessus at the sites of recent cosmetic surgery. All had surgery performed in the developing world. The mean age of these patients was 36 years (range, 29-44 years). There was a delay of up to 16 weeks between the initial presentation and correct diagnosis. All patients were treated with surgical drainage and combination antibiotics with complete resolution.
CONCLUSIONS: We present series of patients with mycobacterial infections after cosmetic surgery in the developing world. This may be related to the endemic nature of these bacteria and/or inadequate sterilization or sterile technique. Due to low domestic incidence of these infections, diagnosis may be difficult and/or delayed. Consulting physicians should have a low threshold to consider atypical etiologies in such scenarios. LEVEL OF EVIDENCE: 5 Therapeutic.
© 2016 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and permission: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27095310     DOI: 10.1093/asj/sjw047

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN: 1090-820X            Impact factor:   4.283


  5 in total

1.  Resistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384.

Authors:  Iman Halloum; Albertus Viljoen; Varun Khanna; Derek Craig; Christiane Bouchier; Roland Brosch; Geoffrey Coxon; Laurent Kremer
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

2.  Mutations in the MAB_2299c TetR Regulator Confer Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.

Authors:  Matthias Richard; Ana Victoria Gutiérrez; Albertus Viljoen; Daniela Rodriguez-Rincon; Françoise Roquet-Baneres; Mickael Blaise; Isobel Everall; Julian Parkhill; R Andres Floto; Laurent Kremer
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

3.  Erythema nodosum due to Mycobacterium abscessus infection complicating autologous fat transfer.

Authors:  Chang Su; Shawn E Cowper; Sarika Ramachandran; Alicia J Little
Journal:  Int J Womens Dermatol       Date:  2020-05-27

Review 4.  Medical Tourism in Aesthetic Breast Surgery: A Systematic Review.

Authors:  Susan McCrossan; Serena Martin; Christopher Hill
Journal:  Aesthetic Plast Surg       Date:  2021-04-19       Impact factor: 2.326

5.  Treatment of mycobacteriosis in a patient with compatible symptoms after a cesarean delivery.

Authors:  Carina Scanoni Maia; Paulo Sérgio Ramos de Araújo; Haiana Charifker Schindler; Jardel Pereira Soares; Ana Sofia Cruz; José Reginaldo Alves de Queiroz Júnior; Fernanda das Chagas Angelo Mendes Tenorio; Juliana Pinto de Medeiros; Bruno Mendes Tenorio; Gyl Everson de Souza Maciel; Rosa Valéria da Silva Amorim; Sylvia Lemos Hinrichsen
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-04-23       Impact factor: 1.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.